 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ( Lifecore or the Company ) (NASDAQ: LFCR). Such investors...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

This is a signal that LFCR's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Lifecore Biomedical (LFCR, $7.81) RSI Indicator left the oversold zone on September 13, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lifecore Biomedical, Inc. - LFCR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. ( Lifecore or the Company ) (NASDAQ: LFCR). Such investors...

Lifecore Biomedical, Inc. (LFCR) Q4 2023 Earnings Call Transcript

Preview: Lifecore Biomedical's Earnings

Lifecore Biomedical (LFCR, $8.55) RSI Indicator left the oversold zone on August 23, 2023

Lifecore Biomedical gets Nasdaq noncompliance notice

CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (Lifecore or the Company), a fully integrated contract development and manufacturing organization (CDMO), today announced that it will host a conference call to discuss fiscal 2023 fourth quarter financial results. The live ...

Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT

CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the Company) announced today that it received a notice (Notice) on August 17, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq) stating that the Company is not in compliance ...

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report

Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It operates through the following business segments: Lifecore, Curation Foods, and Others. The Lifecore segment focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Curation Foods segment is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. The Others segment is Corporate, which includes corporate general and administrative expenses, Non Lifecore and non-Curation Food interest income, interest expense, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Chaska, MN.

Watchers	549
52-Wk Low	$1.52
52-Wk High	$11.46

Market Cap	$240.15M
Volume (M)	37,770.00
52-Wk High	$11.46
52-Wk Low	$1.52

LFCR Lifecore Biomedical Inc

About

Feed

News

Sentiment

Earnings

Fundamentals